Article Information
History
- January 2, 2022.
Article Versions
- Version 1 (March 9, 2021 - 10:42).
- Version 2 (September 4, 2021 - 09:49).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Rebecca Cordery1,
- Lucy Reeves2,
- Jie Zhou2,
- Aileen Rowan2,
- Patricia Watber2,
- Carolina Rosadas2,
- Michael Crone2,
- Marko Storch2,
- Paul Freemont2,
- Lucy Mosscrop2,
- Alice Cowley1,
- Gina Zelent1,
- Kate Bisset1,
- Holly Le Blond1,
- Sadie Regmi1,
- Christian Buckingham2,
- Ramlah Junaideen2,
- Nadia Abdulla2,
- Joseph Eliahoo3,
- Miranda Mindlin1,
- Theresa Lamagni4,
- Wendy Barclay2,
- Graham P. Taylor2 and
- Shiranee Sriskandan2,5,*
- 1London Health Protection Teams, United Kingdom Health Security Agency
- 2Department of Infectious Disease, Imperial College London, London, UK
- 3Statistical Advisory Service, Imperial College London, London, UK
- 4COVID-19 EpiCell, United Kingdom Health Security Agency
- 5NIHR Health Protection Research Unit in Healthcare-associated infections and AMR
- ↵*Correspondence:
Professor Shiranee Sriskandan, Department of Infectious Disease, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN s.sriskandan{at}imperial.ac.uk